• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: EDWARDS LIFESCIENCES COMMANDER DELIVERY SYSTEM; AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIVERED

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

EDWARDS LIFESCIENCES COMMANDER DELIVERY SYSTEM; AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIVERED Back to Search Results
Model Number 9750CM23A
Device Problems Inflation Problem (1310); Material Deformation (2976)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 12/07/2023
Event Type  malfunction  
Manufacturer Narrative
The investigation is ongoing.H3 other text : device will not be returned.
 
Event Description
During a tavr procedure using a 23mm sapien 3 ultra valve via transfemoral approach, the balloon was slightly misaligned by 1mm.The team decided to still deploy the valve, the balloon ruptured before the extra cc could be pushed in.The team was able to remove the balloon without issue and post-dilated dilated with a new 23mm delivery system +1cc.No patient injury was reported.
 
Manufacturer Narrative
Correction to h6; component code, type of investigation, investigation findings, investigation conclusion.The 23mm commander delivery system (ds) was not returned for examination.Due to the unavailability of the complaint device, engineering was unable to perform any visual inspection, functional testing, or dimensional analysis.The 3mensio imagery showed calcification present within the patient's aortic root.A device history record (dhr) review was performed and did not reveal any manufacturing nonconformance issues that would have contributed to the event.A lot history review was performed and revealed no other complaints relating to the complaint code.The following instructions for use (ifu) were reviewed: commander delivery system, device preparation training manual, and the procedural training manual.Based on this review, no ifu/training deficiencies were identified.A review of edwards lifesciences risk management documentation was performed for this case.The reported event is an anticipated risk of the transcatheter heart valve procedure, additional assessment of the failure mode is not required at this time.The reported event of balloon burst and valve not between alignment markers were unable to be confirmed as no device or relevant imagery showing the misaligned valve and balloon burst during deployment was provided.Due to the unavailability of the device, engineering was unable to perform any visual, functional, or dimensional analysis; therefore, a manufacturing non-conformance was unable to be determined.Additionally, a review of the dhr and lot history did not provide any indication that a manufacturing non-conformance would have contributed to the complaint.A review of the ifu and training manuals revealed no deficiencies.Furthermore, no abnormalities were reported during device preparation or valve alignment.The complaint description states, "the team decided to still deploy the valve, the balloon ruptured before the extra cc could be pushed in".Additionally, per the 3mensio review, calcification was present within the patient's aortic root.The balloon burst could be potentially from multiple factors (i.E.Calcified annulus/leaflets, additional inflation volume, and previous implanted valve).While the balloons are sufficiently designed and tested to ensure the burst pressure is at or above the rated burst pressure, calcified nodules can compromise the structure of the balloon wall via the following mechanisms such as puncture, local overstretching, open cell impingement, or stress concentration.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
COMMANDER DELIVERY SYSTEM
Type of Device
AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIVERED
Manufacturer (Section D)
EDWARDS LIFESCIENCES
1 edwards way
irvine CA 92614
Manufacturer (Section G)
EDWARDS LIFESCIENCES
1 edwards way
irvine CA 92614
Manufacturer Contact
renee van dorne
1 edwards way
irvine, CA 92614
9492506385
MDR Report Key18368915
MDR Text Key331097321
Report Number2015691-2023-18622
Device Sequence Number1
Product Code NPT
UDI-Device Identifier00690103207828
UDI-Public(01)00690103207828(17)250416(10)65098683
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P140031
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,User Facility,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 02/12/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model Number9750CM23A
Device Lot Number65098683
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Initial Date Manufacturer Received 12/07/2023
Initial Date FDA Received12/20/2023
Supplement Dates Manufacturer Received02/09/2024
Supplement Dates FDA Received02/12/2024
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured05/19/2023
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient SexFemale
-
-